Sun, Oct 26, 2014, 5:55 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

MiMedx Group, Inc. Message Board

  • stemcellmagnet stemcellmagnet Sep 12, 2013 1:26 PM Flag

    Untitled Letter could leave Mimedx in a position of strength

    FDA is concerned about Safety and Efficacy. The fact that Mimedx has sold close to 180,000 units without one "ADVERSE EFFECT" clearly makes them the leader in this category. The FDA has no desire to shut down a company who's product is so effective especially in the Veteran's Hospital. By choosing the market Leader and Pete has already said his goal is to get the FDA completely happy and comfortable with the Mimedx process. KEEPING IN MIND MIMEDX HAS HAD 2 INSPECTIONS AND PASSED WITH FLYING COLORS! They were both granted NAI's So when Mimedx makes the FDA happy this will put up another roadblock for the competition to try and stay in the race. In addition this CMS savings of 75 million is another roadblocks for the competition. It should be an interesting race!

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
MDXG
9.13+0.01(+0.11%)Oct 24 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.